Because of recent advancements in reproductive technology, oocytes have attained an increasingly enriched value as a unique cell population in the production of offspring. The growing oocytes in the ovary are an immediate potential source that serve this need; however, complete oocyte growth before use is crucial. Our research objective was to create in vitro-grown (IVG) oocytes that would have the ability to perform specialized activities, including nuclear reprogramming, as an alternative to in vivo-grown oocytes. Bovine oocyte-granulosa cell complexes with a mean oocyte diameter of approximately 100 lm were cultured on Millicell membrane inserts, with culture medium supplemented with 4% polyvinylpyrrolidone (molecular weight, 360 000), 20 ng/ml androstenedione, 2 mM hypoxanthine, and 5 ng/ml bone morphogenetic protein 7. Oocyte viability after the 14-day culture period was 95%, and there was a 71% increase in oocyte volume. Upon induction of oocyte maturation, 61% of the IVG oocytes extruded a polar body. Eighty-four percent of the reconstructed IVG oocytes that used cumulus cells as donor cells underwent cleavage, and half of them became blastocysts. DNA methylation analyses of the satellite I and II regions of the blastocysts revealed a similar highly methylated status in the cloned embryos derived from in vivo-grown and IVG oocytes. Finally, one of the nine embryos reconstructed from the IVG oocytes developed into a living calf following embryo transfer. Fertility of the offspring was confirmed. In conclusion, the potential of a proportion of the IVG oocytes was comparable to that of in vivo-grown oocytes.
INTRODUCTION
Because of recent advancements in reproductive technology, oocytes have attained an increasingly enriched value as a unique cell population that is able to produce offspring. In particular, promising oocytes are of an inestimable value in the field of fertility treatment and preservation [1] . An immediate potential source of oocytes is ovarian follicles, which are continuously growing in the ovary. Culturing such oocytes to their full size requires a straightforward approach, and several culture systems have been developed for that purpose, as reviewed in reference [2] . The one requirement is that oocyte growth should be completed so that the resulting embryos can develop to term and the offspring can develop to fertile adults. In large mammals, the fulfillment of this requirement is extremely challenging and time consuming.
The oocyte is characterized by cytoplasm (ooplasm) that is specialized in quantity and quality, which is necessary for events until zygotic transcription begins to control embryogenesis [3] . Oocyte growth in mammals takes several weeks or even months. In a large nucleus called the germinal vesicle (GV), the molecules are progressively expressed that provide the structural and functional bases for the oocyte [4] . One of the best characterized processes is the acquisition of meiotic competence. Meiotic competence is gradually acquired when oocytes reach 80%-90% of their maximum diameter (mice [5] ; pig [6, 7] ; cattle [8] ) as a result of the expression and accumulation of specific kinases and phosphatases (mice [9] [10] [11] [12] [13] ; pig [7, [14] [15] [16] ; goat [17] ). Developmental competence is acquired subsequently, although there appears to be a slight overlap in mice in the timing of acquisitions of meiotic competence to the progression to metaphase II and the developmental competence to the blastocyst stage [18] . In contrast, the completion of growth does not ensure that bovine oocytes become viable embryos with the competence to develop to term; rather, adequate oocyte chromatin status, which is achieved during final follicular growth, has been suggested to represent the readiness of the oocytes [19] . However, most follicles and oocytes degenerate without growing to mature stages in the ovary. Oocyte-specific genomic imprinting in growing oocytes has also been indicated in mice [20, 21] and cattle [22] .
The first successful culture was achieved in the work of Eppig and Schroeder [23] , who obtained mouse offspring from the oocyte-granulosa cell complexes prepared from preantral follicles. Later, the team developed oocytes from primordial follicles [24] by using the tandem combination of ovarian organ culture and isolated complex culture. The culture system for the oocyte-granulosa cell complexes has been modified and applied to bovine oocytes around the late mid-growth phase [25] . A bovine oocyte has a size (!125 lm) that is comparable with those of human [26] and pig oocytes [6] . Technically, oocytes that are 100 lm in diameter are approximately 50% of their maximum volume. They are small and cannot mature [25] . With the use of the bovine 2-week culture system, a proportion of oocytes could develop the capabilities of meiotic maturation, fertilization, and embryonic development [25] . However, competence of the oocytes grown in vitro still has not matched that of oocytes grown in vivo. Bovine oocytes provide a unique opportunity to refine the technology, and the use of bovine oocytes as a model system is potentially applicable to other large mammal species in which fully grown oocytes may be difficult to obtain.
In addition, a large amount of research now indicates that oocytes can possess the uncanny ability to reprogram transferred somatic cell nuclei [27] . Despite remarkable advances in nuclear transfer (NT) technology [28] [29] [30] , animal cloning continues to be difficult, mainly because of insufficient reprogramming of the transferred nucleus [27] . The preparation of highly qualified cytoplasts is an essential task undertaken for successful cloning. In mice, ovulated ova are used exclusively as the source of cytoplasts to create live offspring from NT embryos [31] . To the best of our knowledge, no mice offspring have yet been produced from NT embryos prepared from in vitro-matured (IVM) oocytes, despite there being efficient culture systems for mouse oocyte maturation. However, in cattle and pigs, IVM oocytes as well as ovulated ova have been used to prepare cytoplasts, and many of the offspring have been obtained from the resulting NT embryos (reviewed in reference [27] ), although with reduced developmental frequencies compared with those from ovulated ova [32] . A question that remains is whether in vitro-grown (IVG) oocytes can make recipient cytoplasts that are competent in supporting the development of NT embryos. However, this question is more difficult to answer than it appears because the investigation has been restricted to mice and cattle, in which, so far, the offspring have been obtained from IVG oocytes (cultured from the state of meiotic incompetence) even through in vitro fertilization [2, 25, 33] . Of these species, IVG oocytes in mice are apparently incompatible with NT technology, considering that even IVM oocytes have not been used for this purpose. Thus, only bovine IVG oocytes at this stage can provide an opportunity to examine their quality and potential as the recipient cytoplasts. Therefore, this study was undertaken to test the hypothesis that bovine IVG oocytes produce recipient cytoplasts with sufficient competence to support the complete development of NT embryos. To this end, we adapted and improved a method of producing IVG oocytes that has been described previously [25] , and aimed to establish a sequential system that incorporated in vitro growth and maturation of bovine oocytes to produce oocytes that were as capable as oocytes grown in vivo.
MATERIALS AND METHODS

Chemicals
Unless otherwise specified, chemicals were purchased from Sigma-Aldrich Corporation (St. Louis, MO). The concentration of supplemental fluid in the medium was expressed as a volume/volume percentage.
Collection of Oocyte-Granulosa Cell Complexes
From a total of 310 ovaries collected from Japanese Black or F 1 (Japanese Black 3 Holstein) cows at an abattoir, follicles 0.5-0.8 mm in diameter were dissected and placed in minimum essential medium (MEM; pH 7.2, Nissui Pharmaceutical Co., Ltd., Tokyo, Japan). Oocyte-granulosa cell complexes were collected from the follicles as described previously [25] . Oocyte-cumulus cell complexes isolated from antral follicles 3-6 mm in diameter were used as the in vivo-grown control oocytes. Details of the collection procedure are described in the Supplemental Materials and Methods (all Supplemental Data are available online at www.biolreprod.org). Only healthy looking oocytes that were 90-106 lm in diameter (1227 oocytes in 35 experiments) were introduced to the culture.
In Vitro Growth of Oocytes
The general experimental design is shown in Supplemental Figure S1 . The culture was started on Day 0 and continued until Day 14. All cultures were maintained at 38.58C in incubators. The medium used for oocyte growth was a modified TCM-199 solution described previously [34] with modifications. Briefly, TCM-199 was supplemented with 1 mM sodium pyruvate, 40 mg/ml polyvinylpyrrolidone (PVP; molecular weight [MW] , 360 000), 0.08 mg/ml kanamycin sulfate, 0.3 mM cysteine, 1 lM vitamin B 12 , 0.4 lM biotin, 150 lM ascorbic acid 2-glucoside (AA2G; Hayashibara Co., Ltd., Okayama, Japan), 5% fetal bovine serum (FBS; Thermo Fisher Scientific, Inc., Logan, UT), 0.685 mM GlutaMAX (Life Technologies, Carlsbad, CA), 1% MEM vitamin mixture (Life Technologies), and 0.5% StemPro nutrient supplements (Life Technologies). The medium was also supplemented with 20 ng/ml androstenedione [35] and 2 mM hypoxanthine [36] . In some initial experiments, the effects on promotion of oocyte growth with the supplementation of bone morphogenetic protein 7 (BMP7; R&D Systems, Inc., Minneapolis, MN) in culture medium were examined.
Unless specifically stated otherwise, the oocyte-granulosa cell complexes were placed in groups on Millicell inserts (30-mm diameter, 0.4-lm pore size, product no. PICMORG50; EMD Millipore, Billerica, MA), which were set in Petri dishes (Falcon no. 351007; Becton Dickinson and Co., Franklin Lakes, NJ). In total, 1 and 5 ml of medium were placed on the membrane (top) and in the dish (bottom), respectively. In some experiments, complexes were also cultured on Biocoat cell culture inserts (product no. 35442; Becton Dickinson), which were coated with collagen I, and that fit in a 6-well culture plate. The culture atmosphere was 5% O 2 , 5% CO 2 , and 90% N 2 from Day 0 to Day 3 and 5% CO 2 in air from Day 3 to Day 14 [34] . Half the medium was replaced with fresh medium on Days 3, 6, 9, and 12.
Oocyte diameters were remeasured on Day 1 to exclude the possibility that oocytes that were out of the desired range (90-106 lm) or those showing degenerated morphology. In total, 92.4% of the oocytes (1134/1227) met the requirements (mean 6 SD of 16.2 6 4.5 oocytes per insert). After the 14-day culture period, the oocyte-cumulus cell complexes were extracted from the complexes with a fine pipette. Oocytes were considered live when they showed no signs of degeneration, such as insubstantial cytoplasm or membrane disruption, and were covered with cumulus cells over at least half of their surface. Oocyte/embryos were manipulated on a plate set at 38.08C, except for the procedures performed at room temperature (i.e., donor cell-cytoplast fusion and calcium ionophore treatment).
In Vitro Maturation of Oocytes
Oocyte maturation was induced by maintaining meiotic arrest (16 h) and facilitating oocyte maturation (20 h ). The basal medium was a modified TCM-199 solution with essentially the same composition as that used for oocyte growth, except that it was free of PVP and the StemPro nutrient supplement. For the arresting period (16 h), the basal medium was supplemented with 12.5 lM (s)-roscovitine (Enzo Life Sciences, Inc., Plymouth Meeting, PA), an inhibitor of cyclin-dependent kinases [37] , and 100 lM milrinone, an inhibitor of phosphodiesterase [38, 39] . After the arresting period, the oocyte-cumulus cell complexes were washed five times to remove the inhibitors and cultured for 20 h in the basal medium to facilitate oocyte maturation. The IVG oocytes and in vivo-grown oocytes that extruded the first polar body are referred to as the IVG-IVM oocytes and in vivo-IVM oocytes, respectively. More details about culture conditions are provided in Supplemental Materials and Methods.
Oocyte Enucleation
Oocyte enucleation and reconstruction with the donor cell was performed as described previously [40] in TCM-199 medium containing 20 mM HEPES, 5 mM sodium bicarbonate, 1 mM sodium pyruvate, and 0.08 mg/ml kanamycin sulfate (hereafter referred to as NT medium). NT medium was used with supplementations suitable for each procedure as described in Supplemental Materials and Methods; the final medium was called NT medium (þ supplemented substance). Enucleation was performed in NT medium (þ 20% FBS and 2.5 lg/ml cytochalasin D). Successfully enucleated oocytes were washed five times with NT medium (þ 10% FBS and 50 lM 2-mercaptoethanol) prior to coupling with the donor cell.
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Preparation of Donor Cells
Cumulus cells obtained after maturation of the control oocyteÀcumulus cell complexes were used as nuclei donors [41, 42] . The cumulus cells dispersed with the help of hyaluronidase were cultured to confluency as described previously [40] . Details about preparation of donor cells are provided in Supplemental Materials and Methods.
Donor Cell-Cytoplast Fusion and Activation
The donor cell was inserted into the perivitelline space in NT medium (þ 20% FBS, 2.5 lg/ml cytochalasin D, 50 lg/ml phytohemagglutinin, and 50 lM 2-mercaptoethanol), and the couples were centrifuged for 1 min at 390 3 g before being transferred into Zimmermann fusion medium [43] . The fusion medium was prepared by excluding the calcium chloride in the original composition to avoid the simultaneous occurrence of fusion and parthenogenetic activation [44] ; the composition of the medium was 280 mM sucrose, 0.5 mM magnesium acetate tetrahydrate, 1 mM potassium phosphate dibasic, 0.1 mM glutathione, and 3 mg/ml bovine serum albumin. A single direct-current pulse of 30 V was applied to the couples for 10 lsec, using an electrocell-fusion generator (LF101; Nepa Gene Co., Ltd., Chiba, Japan). The couples were then incubated in modified calcium-free MEM. The fusion took place within 10-30 min in most cases. Only couples that fused within 1 h were cultured for 3 h in NT medium (þ10% FBS) until chemical activation treatment. This and all subsequent cultures were conducted in an atmosphere of 5% O 2 , 5% CO 2 , and 90% N 2 . The reconstructed oocytes were then exposed to 5 lM calcium ionophore A23187 for 5 min at room temperature [45] in NT medium (þ 4 mg/ ml PVP [MW, 40 000]), in conjunction with subsequent 5-h treatment with 10 lg/ml cycloheximide and 2.5 lg/ml cytochalasin D [45] in NT medium (þ 3 mg/ml bovine serum albumin). The NT oocytes (or embryos) from the IVG-IVM oocytes are referred to as the IVG-NT oocytes or IVG-NT embryos, depending on the developmental stages. Likewise, NT oocytes (or embryos) from the in vivo-IVM oocytes are referred to as the in vivo-NT oocytes or in vivo-NT embryos.
Embryo Culture
After being treated with cycloheximide, the reconstructed oocytes were cultured with a synthetic oviduct fluid medium (SOFaaci), previously described by Holm et al. [46] with modification. During the first 4 days, the embryos were cultured in microdrops of serum-free medium (2 ll/embryo) overlaid with paraffin oil. Following this, half of the medium was replaced with fresh medium containing 10% FBS. Development to the blastocyst stage was determined 8 days post-NT. Blastocysts were either transferred to foster mothers or vitrified and preserved with a Cryotop device (Kitazato BioPharma Co., Ltd., Shizuoka, Japan) for later use or sampled for genomic DNA methylation analysis. When appropriate, the blastocysts were subjected to one of the treatments before 8 days.
Embryo Transfer
All animal care and embryo transfers were approved by the Committee on Animal Experimentation of the Tohoku Agricultural Research Center and conducted according to its guidelines. Recipient cows were synchronized for estrus with the insertion of a controlled intravaginal drug-releasing device (EAZI-Breed; InterAg, Hamilton, New Zealand) for administration of 0.5 mg of cloprostenol, a prostaglandin F2a analog (Estrumate; Nagase Medicals Co., Ltd., Itami, Japan) for 4-8 days. Six fresh blastocysts and three vitrifiedwarmed blastocysts were nonsurgically transferred into nine recipient cows.
Genomic DNA Methylation Analysis
Genomic DNA was prepared from the oocytes (collected on Days 0 and 14), in vivo-grown oocytes, blastocysts, and cumulus cells. Twenty oocytes that were denuded completely were pooled for each sample. The blastocysts were individually sampled, and cumulus cells were collected from the remaining donor cell populations prepared for NT. All the cells were washed with PBS containing 1 mg/ml polyvinyl alcohol prior to digestion in DNA lysis buffer [21] . Genomic DNA was extracted with standard procedures, and the bisulfite treatment of DNA was performed as described previously [21] . Regions of interest, including the satellite-I, satellite-II, a-satellite, and art2 regions, were amplified by polymerase chain reactions. The primers used were previously described by Kang et al. [47, 48] . Primer sequences are listed in Supplemental  Table S1 .
Total RNA Extraction from Oocytes and Microarray Analyses
From RNA extraction to microarray analyses, a system optimized for small quantities of total RNA from samples [49] was used. Fragmented cRNA samples (10 lg) were hybridized to the GeneChip bovine genome array (Affymetrix, Inc., Santa Clara, CA) for 12 oocytes: the IVG-IVM oocytes (n ¼ 6) and in vivo-IVM oocytes (n ¼ 6). The oocytes were sampled individually in order to examine whether there was possible (extensive) heterogeneity in the oocyte population after growth in vitro. Details of RNA extraction and array analyses are shown in Supplemental Materials and Methods.
Oocyte Fixation and Examination
Two types of oocyte fixation methods were used according to the purposes of this study: for nuclear status examinations, acetic alcohol was used on the oocytes mounted on glass slides, which were then stained with orcein. For immunofluorescence microscopy observations, oocytes/reconstructed embryos were fixed with a microtubule stabilization buffer [50] as described by Ju et al. [51] with modification. Morphologies of DNA, microtubules, and microfilaments were evaluated according to the method described by Somfai et al. [52] . Details of the method are described in Supplemental Materials and Methods.
Data Presentation and Statistical Analyses
Unless specified, the results of percentage data are given as mean percentages of at least three independent experimental replicates; the variations between experiments are described by SD. For statistical analyses of the percentages, the data were transformed with arcsine transformation. Comparisons between two groups were conducted using Welch t-tests. For multiple comparisons, Tukey tests were used. To compare with the control, Dunnett test was applied. For nonparametric multiple comparisons, Steel-Dwass tests were used. P values ,0.05 were considered significant. Figure 1A shows the early antral follicles (0.5-0.8 mm in diameter) from which the oocyte-granulosa cell complexes were collected. The morphological appearance of the complex after overnight culture is shown in Figure 1B . Oocytes at this stage (Day 1) were incompetent to resume meiosis; 98.2% 6 3.6% of the oocytes (n ¼ 67, 100.2 6 2.6 lm in diameter) remained in the GV stage after 24-h culture with folliclestimulating hormone (FSH), luteinizing hormone (LH), and epidermal growth factor (EGF) (five experiments). One exceptional oocyte ended up in the diakinesis stage.
RESULTS
Oocyte Survival and Growth In Vitro
Two series of experiments were preliminarily conducted in order to determine the detailed culture conditions that maximized the oocyte volume after 14 days of culture. In the first series, the effects of two kinds of cell culture membrane inserts were compared: Biocoat (BD) inserts with collagencoated membranes, which were used in our previous study [25] , and Millicell inserts for organ culture. Both of the membrane inserts allowed the complexes to form a welldeveloped dome-like structure (Fig. 1, C and D) . However, a distinct difference was found in terms of the degree of granulosa cell migration and proliferation over to the marginal areas between the domes; vigorous cell migration and proliferation was observed on Biocoat inserts (Fig. 1E) but not on Millicell inserts (Fig. 1F) . No appreciable differences were observed between the two groups in regard to the morphology of the oocyte-cumulus cell complexes that were recovered from the domes. However, the volume of the oocytes on Millicell inserts was significantly larger than those on Biocoat inserts (P , 0.01) (Fig. 2A) . In the second series of experiments, we examined the effects of BMP7 supplementation (0-50 ng/ml) on the growth of the oocytes cultured for 14 days. As shown in Figure 2B , 5 and 50 ng/ml BMP7 resulted in a positive effect on oocyte growth (P , 0.05). Based on these FERTILITY OF BOVINE OOCYTES AFTER GROWTH IN VITRO results, it was decided that Millicell inserts and 5 ng/ml BMP7 would be used in the culture system for further study. 
FIG. 2.
Comparison of the volumes of oocytes cultured for 14 days in the oocyte-granulosa cell complexes isolated from early antral follicles. A) Complexes were cultured on either Biocoat inserts or Millicell inserts; total numbers of oocytes were 40 and 44, respectively. Data are pooled from three experiments. *Significant differences (P , 0.01; Welch t-test). B) Effects of BMP7 (0, 0.5, 5, and 50 ng/ml) on oocyte growth; total numbers of oocytes were 38, 37, 32, and 33, respectively. Data are pooled from three experiments. Numbers above the box plots indicate the mean diameter (lm) of the oocytes in that group. *Significant differences (P , 0.05; Dunnett test). HIRAO ET AL. and B). Figure 3 , A and B, shows the morphologies of a complex before and after the mechanical removal of the oocyte-cumulus cell complex, respectively. Confocal microscopic examination of the recovered complexes revealed numerous transzonal projections traversing the zona pellucida (Fig. 3C ) from cumulus cells to the oocyte (Fig. 3, D and E) . The oocytes recovered on Day 14 were in the GV stage (n ¼ 37, 3 experiments).
The mean volume of the oocytes increased significantly from approximately 522 600 lm 3 (99.8-lm diameter) to 892 100 lm 3 (119.2-lm diameter) from Day 1 to Day 14 (P , 0.01) (Fig. 4A ). This was a 71% increase, but the IVG oocytes did not achieve the volume of the in vivo-grown oocytes (Fig. 4A) . The relative volumes of the oocytes on Days 1 and 14 were 48% and 82%, respectively, compared with that of the oocytes grown in vivo (Fig. 4A) .
In Vitro Maturation of IVG Oocytes
During the first 16 h, nuclear progression was transiently inhibited by a combination of roscovitine and milrinone (Supplemental Materials and Methods: In Vitro Maturation of Oocytes). The cumulus cell mass, which was compact when collected from the domes (Fig. 5A) , became slightly loose after the arrest (Fig. 5B) . In the following 20 h of culture (Fig. 5C ), cumulus expansion reached a level comparable with that found around the oocytes grown in vivo (Fig. 5D) . The kinetics of meiotic arrest and the maturation of the IVG oocytes are described briefly in Supplemental Materials and Methods.
The first polar body was extruded in 61.1% 6 12.2% of the IVG oocytes (n ¼ 830, 29 experiments). The volume of these IVG-IVM oocytes was 81% compared with that of the in vivo-IVM oocytes (Fig. 4B) . Confocal image analyses indicated the formation of microtubule spindles and the organization of the cortical microfilaments in the IVG-IVM oocytes (n ¼ 21). However, as shown in Figure 5 , E and F, abnormal filamentous actin clusters in the cortical area were observed more frequently in the IVG-IVM oocytes (62%) than in the in vivo-IVM oocytes (9%).
Oocyte Enucleation and Reconstruction
Enucleation was successful in 60%-70% of the oocytes (Fig. 6A) . Reductions in the cytoplasm volume caused by enucleation were 21% and 14% for the IVG-IVM oocytes and in vivo-IVM oocytes, respectively. The resulting volume of the IVG-IVM cytoplasts was 74% the volume of the in vivo-IVM cytoplasts (Fig. 4C) .
Compared with the couples before centrifugation (Fig. 6 , B and C), centrifuged cytoplasts were characterized by cytoplasmic lipids on one side of a semisphere (Fig. 6, D-G) . The intimate contact between the couple was improved by centrifugation (Fig. 6, F and G) , as suggested by the high fusion rate, which was approximately 95% (Fig. 6A) . The rate was 73% 6 14% when couples were fused without centrifugation (n ¼ 53, five preliminary experiments). 
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Preimplantation Development of IVG-NT Embryos
Details of the nuclei and cytoskeleton of the IVG-NT oocytes are described in Supplemental Tables S2 and S3 . Figure 7 , A and B, shows the cleaved embryos on the next day of activation. The cytoplasm of the IVG-NT embryos was partly transparent (Fig. 7A ) compared with the dense-looking cytoplasm of the in vivo-NT embryos (Fig. 7B) . The cleavage rates of the IVG-NT embryos and in vivo-NT embryos were both high after the combined activation treatment (calcium ionophore and cycloheximide) (Fig. 7E) . In both groups, more than 60% of the embryos developed to the blastocyst stage after cleavage (Fig. 7, C-E) . The cleavage of the IVG-NT embryos was very rare after cycloheximide treatment alone, whereas the same treatment led to the cleavage of two-thirds of the in vivo-NT embryos (Fig. 7E) . Figure 8A shows the typical DNA methylation patterns of the satellite-I region of the GV stage oocytes on Days 0 and 14 and those grown in vivo. Methylation levels were approximately 50% in all groups. Figure 8B further indicates that in three (satellite-I, satellite-II, and art2) of the four regions, methylation levels did not differ significantly. Only the asatellite region exhibited lower levels in the growing oocytes than in the oocytes grown in vivo; however, the difference was not significant in IVG oocytes. 
DNA Methylation Profiles
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The electrophoresis patterns shown in Figure 9A suggest no apparent differences between the IVG-NT embryos and in vivo-NT embryos in terms of DNA methylation levels of the satellite-I and -II regions. Hypermethylation status was obvious in both NT embryos (Fig. 9B) . The differences between the groups of NT embryos and those derived from in vitro fertilization were significant (Fig. 9C) . The methylation level of the donor (cumulus) cells was approximately 57% (Fig. 9C) . Figure 10A shows a similarity matrix that was constructed with the Pearson correlation coefficients for the pair-wise comparisons of the 12 oocytes. According to the similarities, data from the in vivo-IVM oocytes and IVG-IVM oocytes were named vivo-1 to vivo-6 and vitro-1 to vitro-6, respectively. In the in vivo-IVM oocyte groups, intense correlations were found between the pairs of vivo-1, vivo-2, and vivo-3 and the pairs of vivo-4, vivo-5, and vivo-6; these groups of three oocytes were classified as B and A, respectively. Similarly, the IVG-IVM oocytes were divided into two groups: two oocytes (vitro-1 and vitro-2), and the other four oocytes were grouped as C and D, respectively.
Gene Transcript Profiles of Metaphase II Oocytes
The transcript profiles were analyzed with principal component analysis (PCA). Figure 10B is representative of the first three components (X-axis ¼ 19.2%, Y-axis ¼ 13.6%, Z-axis ¼ 10.9%). It appeared that the IVG-IVM oocytes were located along the Z-axis but made a minor contribution to the variation associated with the X-axis. However, the in vivo-IVM oocytes were spread out along the X-axis. The oocytes of both these groups contributed to the variation associated with the Y-axis. Figure 10C shows a hierarchical clustering dendrogram of the oocytes. One of the IVG-IVM oocyte groups (Fig. 10D) and one of the in vivo-IVM oocyte groups (Fig. 10B) were more closely related to each other than to the other IVG-IVM oocyte group (Fig. 10C) . The other in vivo-IVM oocytes (Fig.  10A) had a greater clustering distance than the other three groups.
Birth of the Calf and Growth to a Fertile Adult
From one of the freshly transferred embryos, a female calf weighing 45 kg was delivered (Day 279) by induced parturition. The calf was born without any obvious abnormalities, except for a high birth weight. Genetic identities of the calf (Japanese Black) and cumulus cells used as the donor were confirmed. At 12 months of age (Supplemental Fig. S3 ), the first ovulation occurred. After artificial insemination was conducted 576 days after birth, its pregnancy was confirmed, which resulted in the birth of a female calf (Japanese Black) with a normal weight of 27 kg (Day 289). 
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DISCUSSION
Here, we described the production of highly competent IVG oocytes and the first cloned animal from a cytoplast that was prepared from the IVG oocytes. Our primary findings are that 1) IVG-IVM oocytes were fully potent and withstood manipulations, such as NT; 2) approximately half of the embryos that were reconstructed with the IVG-IVM ooplasm and donor cumulus cells developed into blastocysts; and 3) restoration of a new totipotent state of the transferred nucleus occurred in the IVG-IVM ooplasm.
In our previous bovine study, several medium supplements were found to be beneficial for sustaining oocyte growth (see reference [53] for review). Of these, PVP [25] , androstenedione (or estradiol) [35] , and hypoxanthine [36] were critically influential. In particular, steroid hormone supplementation was essential to compensate for the absence of products from theca cells [35] . Under appropriate conditions, oocytes and granulosa cells collectively develop a bidirectional communication loop, which stimulates various important events such as antral cavity formation [54] , the preparation of cumulus cell expansion [55] , and the acquisition of developmental competence by the oocytes [56] . All these features were realized in the present study, suggesting that bidirectional communication was reestablished in vitro.
Considering the various activities of theca cells and their factors that are involved in granulosa cell regulation [57] , it is unlikely that androstenedione supplementation alone could fully substitute for the theca cell-derived factors, which may potentially benefit cultured oocytes. Among such factors, BMP7, which is expressed by theca cells [58] and which uses ActRII of granulosa cells as a receptor [59] , has been shown to promote granulosa cell proliferation in rats [60] and reduce cumulus cell apoptosis in cattle [61] . Although not as definite as the influence of androstenedione which has been shown in a previous study [35] , the results of the present study suggested that BMP7 treatment can increase the growth of the oocytes that were cultured in the oocyte-granulosa cell complexes (Fig.  2B) . The observed increase in oocyte size probably reflected improved granulosa cell activities induced by BMP7 treatment. This result represented another example of compensating, in part, for the absence of theca cells by adding factors to the culture medium. When some other potential theca cell-derived factors that can benefit oocyte growth are characterized, the same approach should be able to add size and perhaps quality to the oocytes grown in vitro.
Another modification that was made to the culture system from the previous study [25] was the use of Millicell inserts in place of Biocoat inserts because Millicell inserts resulted in a more positive effect on the growth of the oocytes than Biocoat inserts. However, it should be noted that the characteristic dome-like structures were developed by the oocyte-granulosa cell complexes on both types of inserts. Within the complexes, the oocytes were separated from the membrane inserts by layers of granulosa cells. Thus, the reason for the difference that emerged between the oocytes due to different inserts was not certain. A manifest difference between the two groups was the more active outgrowth of granulosa cells radiating away from the complexes on Biocoat inserts than on Millicell inserts. Because the collagen coating can facilitate the adherence of the complexes, the different outcomes may be attributable to the collagen coating on the membrane of Biocoat inserts. The effects of the collagen-coated membranes, when combined with the culture medium that was used in the present study, may have been exaggerated because a proportion of the complexes on Biocoat inserts had become almost flat within a HIRAO ET AL. day after seeding (Supplemental Fig. S4 ). This initial deformation of the complexes might have adversely affected the physical association between the oocytes and the accompanying granulosa cells.
Only 5% of the oocytes degenerated during the 14-day culture period. In the bovine ovary, approximately 14 days are required for follicular growth to reach 8.56 mm in diameter from 0.68 mm [62] . However, the vast majority of such follicles have been shown to regress in vivo as subordinate follicles during the final stages of follicular development [62, 63] . Thus, had the IVG oocytes in the present study remained in the ovary, most of them would have degenerated. The IVG oocytes survived because of the absence of the mechanisms involved in follicular selection in the ovary. First, the oocytegranulosa cell complexes were nourished by culture medium and not by the vascular network, because deprivation of the vascular system is a major cause of oocyte death in the ovary [64] . Second, the oocytes nearly exposed to culture medium have a better chance of escaping detrimental influences than the oocytes in the follicle that cannot escape when most neighboring cells are dying. In fact, small groups of granulosa cells were sufficient to reexpand the population around the oocyte in the present study, probably because of the promotion of mitosis [65] and prevention of apoptosis [61] in the cumulus/granulosa cells by the factor(s) from oocytes.
The favorable frequency of preimplantation development by the IVG-NT embryos may imply that only highly qualified IVG-IVM oocytes had been selected through the manipulations of NT. The birth of a calf further indicated the potential of the IVG-IVM ooplasm. However, as for the DNA methylation patterns in the satellite regions, the typical hypermethylation profiles, which were consistently observed in the cloned embryos [66] , have now been extended to the IVG-NT embryos. This observation seemed to be reasonable because the IVG oocytes would, at best, recapitulate the problem if the in vivo-grown oocytes had a problem.
DNA methylation profiles of the GV stage oocytes were also analyzed. According to the study by O'Doherty et al. [22] , the methylation profiles of some maternal imprinting genes still altered the change in bovine oocytes that .100 lm in diameter. Interestingly, however, the genomic contents of 100-lm oocytes can support fetal development to term when they are combined with the appropriate ooplasm and paternal genome [67] . Our observations of 100-lm oocytes suggested that the methylation patterns had almost been established in three of the four regions. The difference from the in vivo-grown oocytes, however, became insignificant when the oocytes were grown in vitro.
Microarray analyses suggested that a proportion of the IVG-IVM oocytes had gene transcript profiles similar to those of the in vivo-IVM oocytes, although the differences derived as a result of different oocyte sources were also revealed. When a PCA was performed, the first component indicated a large variability between the in vivo-IVM oocytes and a limited variability between IVG-IVM oocytes. In contrast, the third component indicated variability between the IVG-IVM oocytes. The Z-axis could represent a component associated with the stress caused by culture. Remarkably, the hierarchical clustering analysis suggested that one group of the in vivo-IVM oocytes resembled a group of the IVG-IVM oocytes more than the other group of in vivo-IVM oocytes. This similarity found in the gene transcript profiles was encouraging for the use of technology to produce IVG oocytes in research and reproductive biology.
Certainly, the culture system used in the present study requires further improvement. First, the IVG oocytes continued to be smaller than the in vivo-grown oocytes. Second, a proportion of the IVG oocytes exhibited abnormalities in the cytoskeleton. Third, additional defined culture conditions, such as the use of serum-free medium and further simplified supplementation, are required. Nevertheless, the present study indicated the IVG oocytes can be as capable as the in vivogrown oocytes, including in the ability to perform highly specialized activities such as nuclear reprograming. These findings have added significance and reliability to the IVG oocytes and the technology that has been developed to create the IVG oocytes.
